Fibrinogen-to-albumin ratio and long-term mortality in oldest-old patients undergoing percutaneous coronary intervention
Abstract Background The fibrinogen-to-albumin ratio (FAR), a novel inflammatory marker, has demonstrated prognostic utility in cardiovascular diseases. However, its role in risk stratification among oldest-old patients (≥ 80 years) undergoing percutaneous coronary intervention (PCI) remains poorly e...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Geriatrics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12877-025-06111-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849767293509173248 |
|---|---|
| author | Yalin Cheng Huimin Li Chenguang Yang Haiyang Gao Peng Li Wanrong Zhu Yuzhu Lu Fusui Ji Xue Yu Wenduo Zhang |
| author_facet | Yalin Cheng Huimin Li Chenguang Yang Haiyang Gao Peng Li Wanrong Zhu Yuzhu Lu Fusui Ji Xue Yu Wenduo Zhang |
| author_sort | Yalin Cheng |
| collection | DOAJ |
| description | Abstract Background The fibrinogen-to-albumin ratio (FAR), a novel inflammatory marker, has demonstrated prognostic utility in cardiovascular diseases. However, its role in risk stratification among oldest-old patients (≥ 80 years) undergoing percutaneous coronary intervention (PCI) remains poorly established. Methods This single-center retrospective cohort study enrolled 641 consecutive patients aged ≥ 80 years with coronary artery disease who underwent PCI between 2015 and 2021. Based on the median FAR value (0.079), patients were divided into higher FAR and lower FAR groups. The endpoints were cardiovascular and all-cause mortality. Multivariable Cox models and restricted cubic splines assessed the associations between FAR and endpoints. Results During a median follow-up of 61 months, 237 deaths (37%) were recorded, of which, 124 (19.3%) were due to cardiovascular disease. The 1-year mortality was 9.3% and 5-year mortality was 27.4%. Kaplan-Meier analysis demonstrated higher FAR levels were significantly associated with increased risk of both cardiovascular and all-cause mortality (log-rank p < 0.001). According to the restricted cubic spline, the association between FAR and mortality was J-shaped. Higher FAR (> 0.079) independently predicted cardiovascular mortality (adjusted HR = 1.49, 95% CI:1.01–2.19, p = 0.045). When tested as a continuous variable, higher FAR levels were associated with a higher risk of cardiovascular (HR = 1.23, 95% CI: 1.04–1.47, p = 0.018) and all-cause mortality (HR = 1.12, 95%CI: 0.98–1.27, p = 0.090) in fully adjusted models. Subgroup analysis revealed that the association between higher FAR levels and increased cardiovascular mortality was significantly stronger in patients with triple-vessel disease (interaction p = 0.039). The associations between FAR and cardiovascular mortality remained robust in the Fine and Gray competing models (HR = 1.31, 95%CI: 1.13–1.52, p = 0.003). Conclusion Higher FAR levels are associated with increased risks of cardiovascular and all-cause mortality in oldest-old patients undergoing PCI. These findings support the potential of FAR for risk stratification in geriatric cardiology. |
| format | Article |
| id | doaj-art-9257e38f2a674a7bb4eb2bffd98958d8 |
| institution | DOAJ |
| issn | 1471-2318 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Geriatrics |
| spelling | doaj-art-9257e38f2a674a7bb4eb2bffd98958d82025-08-20T03:04:15ZengBMCBMC Geriatrics1471-23182025-07-0125111010.1186/s12877-025-06111-4Fibrinogen-to-albumin ratio and long-term mortality in oldest-old patients undergoing percutaneous coronary interventionYalin Cheng0Huimin Li1Chenguang Yang2Haiyang Gao3Peng Li4Wanrong Zhu5Yuzhu Lu6Fusui Ji7Xue Yu8Wenduo Zhang9Department of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical SciencesDepartment of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical CollegeDepartment of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical SciencesDepartment of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical SciencesDepartment of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical SciencesDepartment of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical SciencesDepartment of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical CollegeDepartment of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical SciencesDepartment of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical SciencesDepartment of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical SciencesAbstract Background The fibrinogen-to-albumin ratio (FAR), a novel inflammatory marker, has demonstrated prognostic utility in cardiovascular diseases. However, its role in risk stratification among oldest-old patients (≥ 80 years) undergoing percutaneous coronary intervention (PCI) remains poorly established. Methods This single-center retrospective cohort study enrolled 641 consecutive patients aged ≥ 80 years with coronary artery disease who underwent PCI between 2015 and 2021. Based on the median FAR value (0.079), patients were divided into higher FAR and lower FAR groups. The endpoints were cardiovascular and all-cause mortality. Multivariable Cox models and restricted cubic splines assessed the associations between FAR and endpoints. Results During a median follow-up of 61 months, 237 deaths (37%) were recorded, of which, 124 (19.3%) were due to cardiovascular disease. The 1-year mortality was 9.3% and 5-year mortality was 27.4%. Kaplan-Meier analysis demonstrated higher FAR levels were significantly associated with increased risk of both cardiovascular and all-cause mortality (log-rank p < 0.001). According to the restricted cubic spline, the association between FAR and mortality was J-shaped. Higher FAR (> 0.079) independently predicted cardiovascular mortality (adjusted HR = 1.49, 95% CI:1.01–2.19, p = 0.045). When tested as a continuous variable, higher FAR levels were associated with a higher risk of cardiovascular (HR = 1.23, 95% CI: 1.04–1.47, p = 0.018) and all-cause mortality (HR = 1.12, 95%CI: 0.98–1.27, p = 0.090) in fully adjusted models. Subgroup analysis revealed that the association between higher FAR levels and increased cardiovascular mortality was significantly stronger in patients with triple-vessel disease (interaction p = 0.039). The associations between FAR and cardiovascular mortality remained robust in the Fine and Gray competing models (HR = 1.31, 95%CI: 1.13–1.52, p = 0.003). Conclusion Higher FAR levels are associated with increased risks of cardiovascular and all-cause mortality in oldest-old patients undergoing PCI. These findings support the potential of FAR for risk stratification in geriatric cardiology.https://doi.org/10.1186/s12877-025-06111-4Coronary artery diseaseMortalityFibrinogenAlbumin |
| spellingShingle | Yalin Cheng Huimin Li Chenguang Yang Haiyang Gao Peng Li Wanrong Zhu Yuzhu Lu Fusui Ji Xue Yu Wenduo Zhang Fibrinogen-to-albumin ratio and long-term mortality in oldest-old patients undergoing percutaneous coronary intervention BMC Geriatrics Coronary artery disease Mortality Fibrinogen Albumin |
| title | Fibrinogen-to-albumin ratio and long-term mortality in oldest-old patients undergoing percutaneous coronary intervention |
| title_full | Fibrinogen-to-albumin ratio and long-term mortality in oldest-old patients undergoing percutaneous coronary intervention |
| title_fullStr | Fibrinogen-to-albumin ratio and long-term mortality in oldest-old patients undergoing percutaneous coronary intervention |
| title_full_unstemmed | Fibrinogen-to-albumin ratio and long-term mortality in oldest-old patients undergoing percutaneous coronary intervention |
| title_short | Fibrinogen-to-albumin ratio and long-term mortality in oldest-old patients undergoing percutaneous coronary intervention |
| title_sort | fibrinogen to albumin ratio and long term mortality in oldest old patients undergoing percutaneous coronary intervention |
| topic | Coronary artery disease Mortality Fibrinogen Albumin |
| url | https://doi.org/10.1186/s12877-025-06111-4 |
| work_keys_str_mv | AT yalincheng fibrinogentoalbuminratioandlongtermmortalityinoldestoldpatientsundergoingpercutaneouscoronaryintervention AT huiminli fibrinogentoalbuminratioandlongtermmortalityinoldestoldpatientsundergoingpercutaneouscoronaryintervention AT chenguangyang fibrinogentoalbuminratioandlongtermmortalityinoldestoldpatientsundergoingpercutaneouscoronaryintervention AT haiyanggao fibrinogentoalbuminratioandlongtermmortalityinoldestoldpatientsundergoingpercutaneouscoronaryintervention AT pengli fibrinogentoalbuminratioandlongtermmortalityinoldestoldpatientsundergoingpercutaneouscoronaryintervention AT wanrongzhu fibrinogentoalbuminratioandlongtermmortalityinoldestoldpatientsundergoingpercutaneouscoronaryintervention AT yuzhulu fibrinogentoalbuminratioandlongtermmortalityinoldestoldpatientsundergoingpercutaneouscoronaryintervention AT fusuiji fibrinogentoalbuminratioandlongtermmortalityinoldestoldpatientsundergoingpercutaneouscoronaryintervention AT xueyu fibrinogentoalbuminratioandlongtermmortalityinoldestoldpatientsundergoingpercutaneouscoronaryintervention AT wenduozhang fibrinogentoalbuminratioandlongtermmortalityinoldestoldpatientsundergoingpercutaneouscoronaryintervention |